Rate this post

Ro.co vs Maximus: Compare GLP-1 Programs & Pricing

Side-by-side Ro.coand Maximus: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

Ro.co and Maximus are two established telehealth providers offering GLP-1–based weight management programs. This article compares Ro.co vs Maximus to help you identify which best fits your goals and preferences.

Visit Ro.co
Explore Maximus

Ro.co vs Maximus: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
Ro.co			Brand med access (Code: )	$145.00 — Yes
Maximus		$132.99	(Code: )	— No

Ro.co vs Maximus: Medical Process & Accessibility

Ro.co focuses on fast telehealth intake and clinician approval, while Maximus provides structured follow‑ups and ongoing dose adjustments. Both platforms are fully virtual and partner with licensed U.S. pharmacies for compounded GLP‑1 prescriptions. All services comply with FDA regulations and state telemedicine laws.

Start with Ro.co

Ro.co vs Maximus: Pricing Comparison

Ro.co does not list a public starting price for semaglutide or tirzepatide on its website at this time. Maximus begins tirzepatide at $132.99. Because Maximus offers a concrete price, it is highlighted as the lower option for tirzepatide. Both providers may offer introductory discounts; Ro.co advertises a “Brand med access” promo, while Maximus currently has no listed promo code.

Membership fees also differ: Ro.co requires a $145.00 membership (Yes), which may cover program enrollment and ongoing clinical support. Maximus does not require a membership fee (No), allowing users to pay only for medication and visits.

Compare Maximus Pricing

Ro.co vs Maximus: Clinical Oversight & Support

Both Ro.co and Maximus provide access to licensed clinicians who evaluate eligibility, prescribe GLP‑1 therapy, and monitor safety labs. Ro.co’s model is streamlined for rapid approval, often within 24‑48 hours. Maximus emphasizes a more hands‑on approach, offering regular virtual check‑ins, dose titration guidance, and nutrition counseling throughout the program.

Book a Consultation with Ro.co

Ro.co vs Maximus: Medication Quality & Safety

Each provider dispenses compounded GLP‑1 medications from accredited U.S. pharmacies that follow United States Pharmacopeia (USP) standards. While these compounds are not the brand‑name products Wegovy® or Mounjaro®, they contain the same active ingredients (semaglutide or tirzepatide) and are FDA‑compliant when prescribed by a licensed practitioner. Patients should be aware of potential side effects such as nausea, vomiting, and mild gastrointestinal discomfort, and report any concerns promptly to their telehealth clinician.

Ro.co vs Maximus: Customer Experience

Customer reviews suggest Ro.co excels in affordability and speed of service, making it attractive for users who prioritize quick access. Maximus receives praise for its thorough clinical support, personalized dose adjustments, and proactive follow‑up communication, which can improve adherence and outcomes over the long term.

Explore Maximus Reviews

Ro.co vs Maximus: Final Verdict

Choose Ro.co if you value a low‑cost entry point, rapid onboarding, and are comfortable with a membership model that bundles support services. Opt for Maximus if you prefer a no‑membership structure, want detailed clinical oversight, and are interested in the currently disclosed tirzepatide price of $132.99. Both platforms are reputable, licensed telehealth providers that enable safe, nationwide access to GLP‑1 therapies under physician supervision.

Join Ro.co
Get Started with Maximus

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice